Michelle N. Meyer, Ph.D., J.D.

Assistant Professor and Director of Bioethics Policy,
The Bioethics Program

Michelle N. Meyer is Assistant Professor of Bioethics and Director of Bioethics Policy in the Union Graduate College-Icahn School of Medicine at Mount Sinai Bioethics Program, where she teaches or co-teaches Bioethics and Law; Public Health Ethics; Advanced Bioethics Policy: Philosophical, Economic, and Psychological Foundations; and a survey of contemporary policy issues in the biosciences. She also sits on the advisory boards of the Social Science Genetic Association Consortium, an international consortium that pools and conducts social science research on existing genome-wide association study (GWAS) data, and Making Science Less Weird, an academic initiative to make science less WEIRD (Western, Education, Industrial, Rich, and Democratic) through the use of online platforms for conducting human subjects research. Before joining Union Graduate College, she was an Academic Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; a Greenwall Fellow in Bioethics and Health Policy at The Johns Hopkins and Georgetown Universities; and a Research Fellow at the John F. Kennedy School of Government at Harvard.

Her interdisciplinary scholarship is wide-ranging, but centers on the intersections among law, moral philosophy, and science (including the social sciences). Her writing has appeared, among other places, in the American Journal of Bioethics, the Hastings Center Report, the Kennedy Institute of Ethics Journal, the Harvard Law Review, the Administrative Law Review, Science, Science Progress, and the L.A. Times.

She earned a Ph.D. in religious studies, with a focus on practical ethics, from the University of Virginia and a J.D. from Harvard Law School, where she was an editor of the Harvard Law Review and a founding co-editor of the Harvard Law Review Forum. Following law school, she clerked for Judge Stanley Marcus of the U.S. Court of Appeals for the Eleventh Circuit. She graduated summa cum laude from Dartmouth College, where she studied religious studies and moral philosophy.

Curriculum Vitae >

Recent Publications

Three Challenges for Risk-Proportionate (Research) Regulation: Heterogeneity Among Regulated Entities, Regulator Bias, and Stakeholder Heterogeneity, in THE FUTURE OF HUMAN SUBJECTS RESEARCH REGULATION (I. Glenn Cohen & Holly Fernandez Lynch eds., forth. MIT Press 2014)

Government: When Push Comes to Nudge, L.A. Times, Sept. 29, 2013 (with Christopher Chabris)

Regulating the Production of Knowledge: Research Risk-Benefit Analysis and the Heterogeneity Problem, 65 ADMIN. L. REV. 237 (2013)

Are You Ready for Some…Research? Uncertain Diagnoses, Research Data Privacy, & Preference Heterogeneity, 3 J. of Law (3 THE POST) 99 (2013)

Niels A. Rietveld, et al., GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment, 340 (6139) SCIENCE 1467 

From Evidence-Based Medicine to Evidence-Based Practice, Policy and Politics Column, 43 HASTINGS CENTER REP. 11 (March– April 2013) 

The Subject-Researcher Relationship: In Defense of Contracting Around Default Rules, 11 AM. J. OF BIOETHICS 27 (2011) 

Against One-Size-Fits-All Research Ethics, Policy and Politics Column, 40 HASTINGS CENTER REP. 10 (2010) 

Michelle N. Meyer & James W. Fossett, The More Things Change: The New NIH Guidelines on Stem Cell Research, 19 Kennedy Inst. of Ethics J. (Sept. 2009) 

Recent Activities

“Neither Duty Nor Prohibition: Using Private Ordering to Transcend ‘One-Size-Fits-All’ in Large-Scale Sequencing of Human Beings.” American Society of Human Genetics (ASHG) Annual Meeting, Boston, MA (Oct. 23, 2013) 

“Defining and Measuring IRB Effectiveness.” Organizer, moderator and panelist, American Society of Law, Medicine, and Ethics (ASLME), Seton Hall Law School, Newark, NJ, June 7, 2013. 

“The Ethics of IRB Risk-Benefit Analysis.” Harvard Medical School, Cambridge, MA, April 4, 2013.  

“Risk-Proportionate Regulation and the Challenge from Participant Heterogeneity.” Paper presented at “The Future of Human Subjects Research Regulation” conference, Harvard Law School, Cambridge, MA, May 18, 2012 

For more information about Professor Meyer and her work, visit her personal website. 


© Clarkson, Bioethics Program